1 Lebwohl M,Abel E,Zanolli M.Topicalt herapy for psoriasis.Int J Dermatol,1995,34:673. 2 Lebwohl M.Future psoriasis therapy.Dermatol Clin,1995,13:915. 3 Christophers E,Mrowietz U.The inflammatory infiltrate in psoriasis.Clin Dermatol,1995,13:131. 4 Schroder JM.Inf lammatory mediators and chemoattractants.Clin Dermatol,1995,13:137. 5 Kadunce DP,Krueger G G.Pathogenesis of psoriasis:current concepts.Dermatol Clin,1995,13:723. 6 Ruissen VF,Kerkhof PV,Schalkwijk J.Signal transduction pathways in epidermal proliferation and cutaneous inflammation.Clin Dermatol,1995,13:161. 7 Sunderg JP,Robert W,Dunst and DR.Full-t hickness skin grafts from flaky skin mice to nude mice.J Invest Dermatol,1990,95(S):62. 8 Shao CG,Ye GY,Hu CF,et al.Psoriatic research in China.Int J Dermatol,1992,3:840. 9 Barber N.What constitutes good prescribing? Br Med J,1995,310:923. 10 邵长庚.我国银屑病的流行和防治现状.中华皮肤科杂志,1996,29(2):75. 11 刘承煌.银屑病的临床和研究.上海科研技术文献出版社,1994.238. 12 Kaplan A,Matsue H,Shibaki A.The effects of cyclosporin A and FK506 on proliferation and IL-8p roduction of cultured human keratinocytes.J Dermatol Sci,1995,10:130. 13 Borel JF.Mechanism of action and rationale for cyclosporin A in psorias is.Br J Dermatol,1990,122(Suppl 36):5. 14 Steigleder GK,Mahrle G,Schulze HJ.Topical cyclosporin A in psoriasis.Br J Dermatol,1990,122,113. 15 Koo J,Lee J.Cyclosporine what clinicians need to know.Dermatol Clin,1995,13:897. 16 刘昌孝.药代动力学数据库(临床部分).中国医药科技出版社,1994.456. 17 王贤才主译.临床药物大典.山东:青岛出版社,1994.1458. |